nodes	percent_of_prediction	percent_of_DWPC	metapath
Sertraline—SLC6A4—chronic obstructive pulmonary disease	0.237	0.523	CbGaD
Sertraline—CYP1A2—chronic obstructive pulmonary disease	0.216	0.477	CbGaD
Sertraline—CYP2C19—Arformoterol—chronic obstructive pulmonary disease	0.0323	0.0938	CbGbCtD
Sertraline—CYP2C19—Formoterol—chronic obstructive pulmonary disease	0.0323	0.0938	CbGbCtD
Sertraline—CYP2C9—Formoterol—chronic obstructive pulmonary disease	0.0268	0.078	CbGbCtD
Sertraline—CYP2C9—Arformoterol—chronic obstructive pulmonary disease	0.0268	0.078	CbGbCtD
Sertraline—CYP1A2—Aminophylline—chronic obstructive pulmonary disease	0.0253	0.0736	CbGbCtD
Sertraline—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.0245	0.0713	CbGbCtD
Sertraline—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.0245	0.0713	CbGbCtD
Sertraline—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.0219	0.0636	CbGbCtD
Sertraline—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0206	0.0599	CbGbCtD
Sertraline—CYP2C9—Montelukast—chronic obstructive pulmonary disease	0.0203	0.0591	CbGbCtD
Sertraline—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0139	0.0404	CbGbCtD
Sertraline—CYP2C19—Prednisone—chronic obstructive pulmonary disease	0.0136	0.0394	CbGbCtD
Sertraline—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0133	0.0386	CbGbCtD
Sertraline—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0118	0.0344	CbGbCtD
Sertraline—ABCB1—Prednisolone—chronic obstructive pulmonary disease	0.0116	0.0337	CbGbCtD
Sertraline—ABCB1—Prednisone—chronic obstructive pulmonary disease	0.0109	0.0318	CbGbCtD
Sertraline—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.00694	0.0202	CbGbCtD
Sertraline—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.00655	0.019	CbGbCtD
Sertraline—Maprotiline—CYP1A2—chronic obstructive pulmonary disease	0.000939	0.542	CrCbGaD
Sertraline—Maprotiline—HTR2A—chronic obstructive pulmonary disease	0.000792	0.458	CrCbGaD
Sertraline—SLC6A3—respiratory system—chronic obstructive pulmonary disease	0.000357	0.0639	CbGeAlD
Sertraline—SLC6A4—respiratory system—chronic obstructive pulmonary disease	0.000327	0.0586	CbGeAlD
Sertraline—MAOB—respiratory system—chronic obstructive pulmonary disease	0.000311	0.0557	CbGeAlD
Sertraline—SLC6A2—respiratory system—chronic obstructive pulmonary disease	0.000288	0.0516	CbGeAlD
Sertraline—MAOB—connective tissue—chronic obstructive pulmonary disease	0.000274	0.049	CbGeAlD
Sertraline—SIGMAR1—bronchus—chronic obstructive pulmonary disease	0.000267	0.0479	CbGeAlD
Sertraline—MAOA—respiratory system—chronic obstructive pulmonary disease	0.000265	0.0475	CbGeAlD
Sertraline—SIGMAR1—smooth muscle tissue—chronic obstructive pulmonary disease	0.000262	0.0468	CbGeAlD
Sertraline—MAOB—bronchus—chronic obstructive pulmonary disease	0.000256	0.0458	CbGeAlD
Sertraline—SIGMAR1—trachea—chronic obstructive pulmonary disease	0.00024	0.043	CbGeAlD
Sertraline—MAOA—connective tissue—chronic obstructive pulmonary disease	0.000234	0.0418	CbGeAlD
Sertraline—CYP1A2—respiratory system—chronic obstructive pulmonary disease	0.000221	0.0396	CbGeAlD
Sertraline—MAOA—bronchus—chronic obstructive pulmonary disease	0.000218	0.0391	CbGeAlD
Sertraline—CYP2B6—respiratory system—chronic obstructive pulmonary disease	0.000212	0.038	CbGeAlD
Sertraline—MAOA—trachea—chronic obstructive pulmonary disease	0.000196	0.0351	CbGeAlD
Sertraline—SLC6A3—lung—chronic obstructive pulmonary disease	0.00019	0.0339	CbGeAlD
Sertraline—CYP2B6—bronchus—chronic obstructive pulmonary disease	0.000175	0.0313	CbGeAlD
Sertraline—SLC6A4—lung—chronic obstructive pulmonary disease	0.000174	0.0311	CbGeAlD
Sertraline—SIGMAR1—lung—chronic obstructive pulmonary disease	0.000173	0.0309	CbGeAlD
Sertraline—MAOB—lung—chronic obstructive pulmonary disease	0.000165	0.0296	CbGeAlD
Sertraline—SLC6A2—lung—chronic obstructive pulmonary disease	0.000153	0.0274	CbGeAlD
Sertraline—MAOA—lung—chronic obstructive pulmonary disease	0.000141	0.0252	CbGeAlD
Sertraline—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.00012	0.00079	CcSEcCtD
Sertraline—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.00012	0.000788	CcSEcCtD
Sertraline—Abdominal distension—Prednisolone—chronic obstructive pulmonary disease	0.00012	0.000788	CcSEcCtD
Sertraline—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000119	0.000782	CcSEcCtD
Sertraline—Euphoric mood—Prednisone—chronic obstructive pulmonary disease	0.000119	0.000779	CcSEcCtD
Sertraline—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000118	0.000776	CcSEcCtD
Sertraline—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000118	0.000776	CcSEcCtD
Sertraline—CYP1A2—lung—chronic obstructive pulmonary disease	0.000118	0.0211	CbGeAlD
Sertraline—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000117	0.000768	CcSEcCtD
Sertraline—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000117	0.000768	CcSEcCtD
Sertraline—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	0.000117	0.000768	CcSEcCtD
Sertraline—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000116	0.000764	CcSEcCtD
Sertraline—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000116	0.000764	CcSEcCtD
Sertraline—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.000116	0.000763	CcSEcCtD
Sertraline—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000116	0.000761	CcSEcCtD
Sertraline—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000115	0.000758	CcSEcCtD
Sertraline—Diabetes mellitus—Prednisone—chronic obstructive pulmonary disease	0.000115	0.000757	CcSEcCtD
Sertraline—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000115	0.000754	CcSEcCtD
Sertraline—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000114	0.000751	CcSEcCtD
Sertraline—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000114	0.00075	CcSEcCtD
Sertraline—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000114	0.000749	CcSEcCtD
Sertraline—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000114	0.000749	CcSEcCtD
Sertraline—ABCB1—respiratory system—chronic obstructive pulmonary disease	0.000113	0.0203	CbGeAlD
Sertraline—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000113	0.000744	CcSEcCtD
Sertraline—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000113	0.000744	CcSEcCtD
Sertraline—CYP2B6—lung—chronic obstructive pulmonary disease	0.000113	0.0202	CbGeAlD
Sertraline—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000113	0.00074	CcSEcCtD
Sertraline—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000112	0.000739	CcSEcCtD
Sertraline—Vascular purpura—Prednisone—chronic obstructive pulmonary disease	0.000112	0.000736	CcSEcCtD
Sertraline—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000112	0.000734	CcSEcCtD
Sertraline—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000112	0.000733	CcSEcCtD
Sertraline—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000112	0.000733	CcSEcCtD
Sertraline—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000111	0.000731	CcSEcCtD
Sertraline—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000111	0.000731	CcSEcCtD
Sertraline—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000111	0.000728	CcSEcCtD
Sertraline—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.00011	0.000725	CcSEcCtD
Sertraline—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.00011	0.000724	CcSEcCtD
Sertraline—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.00011	0.000724	CcSEcCtD
Sertraline—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.00011	0.000723	CcSEcCtD
Sertraline—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.00011	0.000721	CcSEcCtD
Sertraline—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000109	0.000716	CcSEcCtD
Sertraline—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000109	0.000714	CcSEcCtD
Sertraline—Weight increased—Prednisolone—chronic obstructive pulmonary disease	0.000108	0.000713	CcSEcCtD
Sertraline—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000108	0.00071	CcSEcCtD
Sertraline—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000108	0.00071	CcSEcCtD
Sertraline—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000108	0.000709	CcSEcCtD
Sertraline—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000108	0.000709	CcSEcCtD
Sertraline—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000108	0.000709	CcSEcCtD
Sertraline—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000108	0.000707	CcSEcCtD
Sertraline—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000107	0.000703	CcSEcCtD
Sertraline—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000107	0.000703	CcSEcCtD
Sertraline—Pain—Formoterol—chronic obstructive pulmonary disease	0.000107	0.000703	CcSEcCtD
Sertraline—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000107	0.000703	CcSEcCtD
Sertraline—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000107	0.000702	CcSEcCtD
Sertraline—Amnesia—Prednisone—chronic obstructive pulmonary disease	0.000107	0.000701	CcSEcCtD
Sertraline—Increased appetite—Prednisone—chronic obstructive pulmonary disease	0.000107	0.000701	CcSEcCtD
Sertraline—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000106	0.000697	CcSEcCtD
Sertraline—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000106	0.000695	CcSEcCtD
Sertraline—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000106	0.000694	CcSEcCtD
Sertraline—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000105	0.000692	CcSEcCtD
Sertraline—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000105	0.00069	CcSEcCtD
Sertraline—Pain—Montelukast—chronic obstructive pulmonary disease	0.000105	0.000689	CcSEcCtD
Sertraline—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.000105	0.000688	CcSEcCtD
Sertraline—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000105	0.000687	CcSEcCtD
Sertraline—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.000104	0.000684	CcSEcCtD
Sertraline—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	0.000104	0.000684	CcSEcCtD
Sertraline—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000104	0.000683	CcSEcCtD
Sertraline—Purpura—Prednisone—chronic obstructive pulmonary disease	0.000104	0.000683	CcSEcCtD
Sertraline—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000104	0.000681	CcSEcCtD
Sertraline—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000104	0.00068	CcSEcCtD
Sertraline—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.000103	0.000679	CcSEcCtD
Sertraline—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000103	0.000677	CcSEcCtD
Sertraline—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000103	0.000677	CcSEcCtD
Sertraline—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000103	0.000677	CcSEcCtD
Sertraline—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000103	0.000675	CcSEcCtD
Sertraline—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000103	0.000674	CcSEcCtD
Sertraline—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000102	0.000672	CcSEcCtD
Sertraline—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000102	0.000672	CcSEcCtD
Sertraline—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000102	0.00067	CcSEcCtD
Sertraline—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000102	0.000669	CcSEcCtD
Sertraline—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000101	0.000664	CcSEcCtD
Sertraline—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000101	0.000664	CcSEcCtD
Sertraline—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.0001	0.000658	CcSEcCtD
Sertraline—Osteoarthritis—Prednisone—chronic obstructive pulmonary disease	0.0001	0.000658	CcSEcCtD
Sertraline—Gastrointestinal haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.0001	0.000658	CcSEcCtD
Sertraline—Urticaria—Formoterol—chronic obstructive pulmonary disease	9.94e-05	0.000653	CcSEcCtD
Sertraline—Urticaria—Arformoterol—chronic obstructive pulmonary disease	9.94e-05	0.000653	CcSEcCtD
Sertraline—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	9.89e-05	0.00065	CcSEcCtD
Sertraline—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	9.89e-05	0.00065	CcSEcCtD
Sertraline—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	9.89e-05	0.00065	CcSEcCtD
Sertraline—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	9.89e-05	0.00065	CcSEcCtD
Sertraline—Affect lability—Prednisone—chronic obstructive pulmonary disease	9.86e-05	0.000648	CcSEcCtD
Sertraline—Vomiting—Tiotropium—chronic obstructive pulmonary disease	9.86e-05	0.000648	CcSEcCtD
Sertraline—Psychotic disorder—Prednisone—chronic obstructive pulmonary disease	9.78e-05	0.000643	CcSEcCtD
Sertraline—Rash—Tiotropium—chronic obstructive pulmonary disease	9.78e-05	0.000642	CcSEcCtD
Sertraline—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	9.77e-05	0.000642	CcSEcCtD
Sertraline—Nausea—Aminophylline—chronic obstructive pulmonary disease	9.77e-05	0.000642	CcSEcCtD
Sertraline—Urticaria—Montelukast—chronic obstructive pulmonary disease	9.74e-05	0.00064	CcSEcCtD
Sertraline—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	9.74e-05	0.00064	CcSEcCtD
Sertraline—Headache—Tiotropium—chronic obstructive pulmonary disease	9.71e-05	0.000638	CcSEcCtD
Sertraline—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	9.71e-05	0.000638	CcSEcCtD
Sertraline—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	9.69e-05	0.000637	CcSEcCtD
Sertraline—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	9.69e-05	0.000637	CcSEcCtD
Sertraline—Face oedema—Prednisone—chronic obstructive pulmonary disease	9.67e-05	0.000636	CcSEcCtD
Sertraline—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	9.66e-05	0.000635	CcSEcCtD
Sertraline—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	9.59e-05	0.00063	CcSEcCtD
Sertraline—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	9.54e-05	0.000627	CcSEcCtD
Sertraline—Mood swings—Prednisone—chronic obstructive pulmonary disease	9.49e-05	0.000624	CcSEcCtD
Sertraline—Urticaria—Salbutamol—chronic obstructive pulmonary disease	9.39e-05	0.000617	CcSEcCtD
Sertraline—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	9.34e-05	0.000614	CcSEcCtD
Sertraline—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	9.34e-05	0.000614	CcSEcCtD
Sertraline—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	9.22e-05	0.000606	CcSEcCtD
Sertraline—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	9.22e-05	0.000606	CcSEcCtD
Sertraline—Nausea—Tiotropium—chronic obstructive pulmonary disease	9.21e-05	0.000605	CcSEcCtD
Sertraline—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	9.19e-05	0.000604	CcSEcCtD
Sertraline—Dry skin—Prednisone—chronic obstructive pulmonary disease	9.18e-05	0.000603	CcSEcCtD
Sertraline—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	9.03e-05	0.000593	CcSEcCtD
Sertraline—Asthenia—Formoterol—chronic obstructive pulmonary disease	8.98e-05	0.00059	CcSEcCtD
Sertraline—Asthenia—Arformoterol—chronic obstructive pulmonary disease	8.98e-05	0.00059	CcSEcCtD
Sertraline—Pruritus—Arformoterol—chronic obstructive pulmonary disease	8.85e-05	0.000582	CcSEcCtD
Sertraline—Pruritus—Formoterol—chronic obstructive pulmonary disease	8.85e-05	0.000582	CcSEcCtD
Sertraline—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	8.84e-05	0.000581	CcSEcCtD
Sertraline—Alanine aminotransferase increased—Prednisone—chronic obstructive pulmonary disease	8.84e-05	0.000581	CcSEcCtD
Sertraline—Asthenia—Montelukast—chronic obstructive pulmonary disease	8.79e-05	0.000578	CcSEcCtD
Sertraline—Abdominal distension—Prednisone—chronic obstructive pulmonary disease	8.72e-05	0.000573	CcSEcCtD
Sertraline—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	8.7e-05	0.000572	CcSEcCtD
Sertraline—Pruritus—Montelukast—chronic obstructive pulmonary disease	8.67e-05	0.00057	CcSEcCtD
Sertraline—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	8.56e-05	0.000563	CcSEcCtD
Sertraline—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	8.56e-05	0.000563	CcSEcCtD
Sertraline—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	8.52e-05	0.00056	CcSEcCtD
Sertraline—Pancreatitis—Prednisone—chronic obstructive pulmonary disease	8.49e-05	0.000558	CcSEcCtD
Sertraline—Asthenia—Salbutamol—chronic obstructive pulmonary disease	8.48e-05	0.000557	CcSEcCtD
Sertraline—Sweating increased—Prednisone—chronic obstructive pulmonary disease	8.44e-05	0.000554	CcSEcCtD
Sertraline—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	8.39e-05	0.000551	CcSEcCtD
Sertraline—ABCB1—trachea—chronic obstructive pulmonary disease	8.38e-05	0.015	CbGeAlD
Sertraline—Pruritus—Salbutamol—chronic obstructive pulmonary disease	8.36e-05	0.000549	CcSEcCtD
Sertraline—Erythema—Prednisolone—chronic obstructive pulmonary disease	8.3e-05	0.000546	CcSEcCtD
Sertraline—Dizziness—Formoterol—chronic obstructive pulmonary disease	8.27e-05	0.000544	CcSEcCtD
Sertraline—Dizziness—Arformoterol—chronic obstructive pulmonary disease	8.27e-05	0.000544	CcSEcCtD
Sertraline—Dizziness—Montelukast—chronic obstructive pulmonary disease	8.1e-05	0.000532	CcSEcCtD
Sertraline—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	8.08e-05	0.000531	CcSEcCtD
Sertraline—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	7.98e-05	0.000524	CcSEcCtD
Sertraline—Vomiting—Formoterol—chronic obstructive pulmonary disease	7.96e-05	0.000523	CcSEcCtD
Sertraline—Vomiting—Arformoterol—chronic obstructive pulmonary disease	7.96e-05	0.000523	CcSEcCtD
Sertraline—Rash—Formoterol—chronic obstructive pulmonary disease	7.89e-05	0.000518	CcSEcCtD
Sertraline—Rash—Arformoterol—chronic obstructive pulmonary disease	7.89e-05	0.000518	CcSEcCtD
Sertraline—Dermatitis—Formoterol—chronic obstructive pulmonary disease	7.88e-05	0.000518	CcSEcCtD
Sertraline—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	7.88e-05	0.000518	CcSEcCtD
Sertraline—Weight increased—Prednisone—chronic obstructive pulmonary disease	7.88e-05	0.000518	CcSEcCtD
Sertraline—Headache—Arformoterol—chronic obstructive pulmonary disease	7.84e-05	0.000515	CcSEcCtD
Sertraline—Headache—Formoterol—chronic obstructive pulmonary disease	7.84e-05	0.000515	CcSEcCtD
Sertraline—Weight decreased—Prednisone—chronic obstructive pulmonary disease	7.83e-05	0.000515	CcSEcCtD
Sertraline—Dizziness—Salbutamol—chronic obstructive pulmonary disease	7.81e-05	0.000513	CcSEcCtD
Sertraline—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	7.81e-05	0.000513	CcSEcCtD
Sertraline—Vomiting—Montelukast—chronic obstructive pulmonary disease	7.79e-05	0.000512	CcSEcCtD
Sertraline—Rash—Montelukast—chronic obstructive pulmonary disease	7.73e-05	0.000508	CcSEcCtD
Sertraline—Dermatitis—Montelukast—chronic obstructive pulmonary disease	7.72e-05	0.000507	CcSEcCtD
Sertraline—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	7.7e-05	0.000506	CcSEcCtD
Sertraline—Depression—Prednisone—chronic obstructive pulmonary disease	7.7e-05	0.000506	CcSEcCtD
Sertraline—Headache—Montelukast—chronic obstructive pulmonary disease	7.68e-05	0.000504	CcSEcCtD
Sertraline—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	7.61e-05	0.0005	CcSEcCtD
Sertraline—Angioedema—Prednisolone—chronic obstructive pulmonary disease	7.59e-05	0.000498	CcSEcCtD
Sertraline—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	7.57e-05	0.000497	CcSEcCtD
Sertraline—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	7.57e-05	0.000497	CcSEcCtD
Sertraline—Vomiting—Salbutamol—chronic obstructive pulmonary disease	7.51e-05	0.000494	CcSEcCtD
Sertraline—Malaise—Prednisolone—chronic obstructive pulmonary disease	7.49e-05	0.000492	CcSEcCtD
Sertraline—Vertigo—Prednisolone—chronic obstructive pulmonary disease	7.46e-05	0.00049	CcSEcCtD
Sertraline—Rash—Salbutamol—chronic obstructive pulmonary disease	7.45e-05	0.000489	CcSEcCtD
Sertraline—Syncope—Prednisolone—chronic obstructive pulmonary disease	7.45e-05	0.000489	CcSEcCtD
Sertraline—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	7.44e-05	0.000489	CcSEcCtD
Sertraline—Nausea—Arformoterol—chronic obstructive pulmonary disease	7.43e-05	0.000488	CcSEcCtD
Sertraline—Nausea—Formoterol—chronic obstructive pulmonary disease	7.43e-05	0.000488	CcSEcCtD
Sertraline—Headache—Salbutamol—chronic obstructive pulmonary disease	7.4e-05	0.000486	CcSEcCtD
Sertraline—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	7.3e-05	0.000479	CcSEcCtD
Sertraline—Nausea—Montelukast—chronic obstructive pulmonary disease	7.28e-05	0.000478	CcSEcCtD
Sertraline—Convulsion—Prednisolone—chronic obstructive pulmonary disease	7.19e-05	0.000473	CcSEcCtD
Sertraline—Hypertension—Prednisolone—chronic obstructive pulmonary disease	7.17e-05	0.000471	CcSEcCtD
Sertraline—Bradycardia—Prednisone—chronic obstructive pulmonary disease	7.06e-05	0.000464	CcSEcCtD
Sertraline—Nausea—Salbutamol—chronic obstructive pulmonary disease	7.02e-05	0.000461	CcSEcCtD
Sertraline—Discomfort—Prednisolone—chronic obstructive pulmonary disease	6.98e-05	0.000459	CcSEcCtD
Sertraline—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	6.97e-05	0.000458	CcSEcCtD
Sertraline—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	6.93e-05	0.000455	CcSEcCtD
Sertraline—Hallucination—Prednisone—chronic obstructive pulmonary disease	6.9e-05	0.000453	CcSEcCtD
Sertraline—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	6.81e-05	0.000448	CcSEcCtD
Sertraline—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	6.78e-05	0.000445	CcSEcCtD
Sertraline—Oedema—Prednisolone—chronic obstructive pulmonary disease	6.78e-05	0.000445	CcSEcCtD
Sertraline—Shock—Prednisolone—chronic obstructive pulmonary disease	6.67e-05	0.000438	CcSEcCtD
Sertraline—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	6.61e-05	0.000435	CcSEcCtD
Sertraline—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	6.55e-05	0.00043	CcSEcCtD
Sertraline—Eye disorder—Prednisone—chronic obstructive pulmonary disease	6.48e-05	0.000426	CcSEcCtD
Sertraline—Flushing—Prednisone—chronic obstructive pulmonary disease	6.43e-05	0.000423	CcSEcCtD
Sertraline—Angiopathy—Prednisone—chronic obstructive pulmonary disease	6.29e-05	0.000413	CcSEcCtD
Sertraline—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	6.26e-05	0.000411	CcSEcCtD
Sertraline—CYP2B6—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	6.25e-05	0.00143	CbGpPWpGaD
Sertraline—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	6.2e-05	0.00142	CbGpPWpGaD
Sertraline—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	6.19e-05	0.000407	CcSEcCtD
Sertraline—CYP2B6—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	6.16e-05	0.00141	CbGpPWpGaD
Sertraline—MAOB—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	6.15e-05	0.0014	CbGpPWpGaD
Sertraline—Insomnia—Prednisolone—chronic obstructive pulmonary disease	6.13e-05	0.000403	CcSEcCtD
Sertraline—Alopecia—Prednisone—chronic obstructive pulmonary disease	6.12e-05	0.000402	CcSEcCtD
Sertraline—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	6.12e-05	0.0014	CbGpPWpGaD
Sertraline—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	6.08e-05	0.0004	CcSEcCtD
Sertraline—Mental disorder—Prednisone—chronic obstructive pulmonary disease	6.07e-05	0.000399	CcSEcCtD
Sertraline—Erythema—Prednisone—chronic obstructive pulmonary disease	6.03e-05	0.000396	CcSEcCtD
Sertraline—Malnutrition—Prednisone—chronic obstructive pulmonary disease	6.03e-05	0.000396	CcSEcCtD
Sertraline—ABCB1—lung—chronic obstructive pulmonary disease	6.02e-05	0.0108	CbGeAlD
Sertraline—MAOB—Metabolism—GC—chronic obstructive pulmonary disease	5.99e-05	0.00137	CbGpPWpGaD
Sertraline—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	5.94e-05	0.00135	CbGpPWpGaD
Sertraline—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	5.92e-05	0.00135	CbGpPWpGaD
Sertraline—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	5.89e-05	0.00134	CbGpPWpGaD
Sertraline—MAOA—Metabolism—APIP—chronic obstructive pulmonary disease	5.83e-05	0.00133	CbGpPWpGaD
Sertraline—ABCB1—HIF-1-alpha transcription factor network—NOS2—chronic obstructive pulmonary disease	5.82e-05	0.00133	CbGpPWpGaD
Sertraline—Pain—Prednisolone—chronic obstructive pulmonary disease	5.79e-05	0.000381	CcSEcCtD
Sertraline—CYP2C19—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	5.68e-05	0.0013	CbGpPWpGaD
Sertraline—CYP2C19—Biological oxidations—GCLC—chronic obstructive pulmonary disease	5.61e-05	0.00128	CbGpPWpGaD
Sertraline—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	5.6e-05	0.000368	CcSEcCtD
Sertraline—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	5.58e-05	0.000367	CcSEcCtD
Sertraline—Anaemia—Prednisone—chronic obstructive pulmonary disease	5.58e-05	0.000366	CcSEcCtD
Sertraline—MAOB—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	5.56e-05	0.00127	CbGpPWpGaD
Sertraline—Agitation—Prednisone—chronic obstructive pulmonary disease	5.54e-05	0.000364	CcSEcCtD
Sertraline—Angioedema—Prednisone—chronic obstructive pulmonary disease	5.51e-05	0.000362	CcSEcCtD
Sertraline—SLC6A4—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	5.51e-05	0.00126	CbGpPWpGaD
Sertraline—Malaise—Prednisone—chronic obstructive pulmonary disease	5.44e-05	0.000357	CcSEcCtD
Sertraline—Vertigo—Prednisone—chronic obstructive pulmonary disease	5.42e-05	0.000356	CcSEcCtD
Sertraline—Syncope—Prednisone—chronic obstructive pulmonary disease	5.41e-05	0.000356	CcSEcCtD
Sertraline—Urticaria—Prednisolone—chronic obstructive pulmonary disease	5.38e-05	0.000354	CcSEcCtD
Sertraline—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	5.34e-05	0.00122	CbGpPWpGaD
Sertraline—SLC6A4—Circadian rythm related genes—SERPINE1—chronic obstructive pulmonary disease	5.31e-05	0.00121	CbGpPWpGaD
Sertraline—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	5.3e-05	0.000348	CcSEcCtD
Sertraline—SLC6A4—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	5.29e-05	0.00121	CbGpPWpGaD
Sertraline—CYP1A2—Phase II conjugation—GSTP1—chronic obstructive pulmonary disease	5.24e-05	0.0012	CbGpPWpGaD
Sertraline—Convulsion—Prednisone—chronic obstructive pulmonary disease	5.23e-05	0.000343	CcSEcCtD
Sertraline—CYP2D6—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	5.22e-05	0.00119	CbGpPWpGaD
Sertraline—CYP2B6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	5.21e-05	0.00119	CbGpPWpGaD
Sertraline—Hypertension—Prednisone—chronic obstructive pulmonary disease	5.21e-05	0.000342	CcSEcCtD
Sertraline—CYP2C9—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	5.18e-05	0.00118	CbGpPWpGaD
Sertraline—CYP2D6—Biological oxidations—GCLC—chronic obstructive pulmonary disease	5.16e-05	0.00118	CbGpPWpGaD
Sertraline—CYP2B6—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	5.14e-05	0.00117	CbGpPWpGaD
Sertraline—Myalgia—Prednisone—chronic obstructive pulmonary disease	5.14e-05	0.000338	CcSEcCtD
Sertraline—Arthralgia—Prednisone—chronic obstructive pulmonary disease	5.14e-05	0.000338	CcSEcCtD
Sertraline—Anxiety—Prednisone—chronic obstructive pulmonary disease	5.12e-05	0.000336	CcSEcCtD
Sertraline—CYP2C9—Biological oxidations—GCLC—chronic obstructive pulmonary disease	5.12e-05	0.00117	CbGpPWpGaD
Sertraline—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	5.1e-05	0.000335	CcSEcCtD
Sertraline—Discomfort—Prednisone—chronic obstructive pulmonary disease	5.08e-05	0.000333	CcSEcCtD
Sertraline—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	5.03e-05	0.00115	CbGpPWpGaD
Sertraline—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	4.99e-05	0.000328	CcSEcCtD
Sertraline—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	4.92e-05	0.000324	CcSEcCtD
Sertraline—Oedema—Prednisone—chronic obstructive pulmonary disease	4.92e-05	0.000324	CcSEcCtD
Sertraline—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—chronic obstructive pulmonary disease	4.9e-05	0.00112	CbGpPWpGaD
Sertraline—Shock—Prednisone—chronic obstructive pulmonary disease	4.84e-05	0.000318	CcSEcCtD
Sertraline—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	4.83e-05	0.000317	CcSEcCtD
Sertraline—CYP1A2—Phase II conjugation—GSTM1—chronic obstructive pulmonary disease	4.82e-05	0.0011	CbGpPWpGaD
Sertraline—Tachycardia—Prednisone—chronic obstructive pulmonary disease	4.81e-05	0.000316	CcSEcCtD
Sertraline—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	4.79e-05	0.00109	CbGpPWpGaD
Sertraline—CYP2B6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	4.79e-05	0.00109	CbGpPWpGaD
Sertraline—Skin disorder—Prednisone—chronic obstructive pulmonary disease	4.78e-05	0.000314	CcSEcCtD
Sertraline—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	4.76e-05	0.000313	CcSEcCtD
Sertraline—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	4.73e-05	0.00108	CbGpPWpGaD
Sertraline—CYP2B6—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	4.72e-05	0.00108	CbGpPWpGaD
Sertraline—CYP2C19—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	4.72e-05	0.00108	CbGpPWpGaD
Sertraline—Anorexia—Prednisone—chronic obstructive pulmonary disease	4.69e-05	0.000308	CcSEcCtD
Sertraline—CYP2C19—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	4.65e-05	0.00106	CbGpPWpGaD
Sertraline—CYP2B6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	4.54e-05	0.00104	CbGpPWpGaD
Sertraline—MAOA—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	4.52e-05	0.00103	CbGpPWpGaD
Sertraline—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	4.49e-05	0.000295	CcSEcCtD
Sertraline—Dizziness—Prednisolone—chronic obstructive pulmonary disease	4.48e-05	0.000294	CcSEcCtD
Sertraline—SLC6A4—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	4.48e-05	0.00102	CbGpPWpGaD
Sertraline—CYP2B6—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	4.48e-05	0.00102	CbGpPWpGaD
Sertraline—Insomnia—Prednisone—chronic obstructive pulmonary disease	4.45e-05	0.000293	CcSEcCtD
Sertraline—CYP1A2—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	4.43e-05	0.00101	CbGpPWpGaD
Sertraline—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	4.42e-05	0.000291	CcSEcCtD
Sertraline—CYP1A2—Biological oxidations—GCLC—chronic obstructive pulmonary disease	4.37e-05	0.000998	CbGpPWpGaD
Sertraline—CYP2D6—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	4.34e-05	0.000991	CbGpPWpGaD
Sertraline—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	4.33e-05	0.000285	CcSEcCtD
Sertraline—MAOA—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	4.33e-05	0.000989	CbGpPWpGaD
Sertraline—SLC6A4—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	4.33e-05	0.000989	CbGpPWpGaD
Sertraline—CYP2C9—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	4.3e-05	0.000982	CbGpPWpGaD
Sertraline—CYP2D6—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	4.28e-05	0.000977	CbGpPWpGaD
Sertraline—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	4.28e-05	0.000281	CcSEcCtD
Sertraline—Rash—Prednisolone—chronic obstructive pulmonary disease	4.27e-05	0.000281	CcSEcCtD
Sertraline—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	4.27e-05	0.00028	CcSEcCtD
Sertraline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—chronic obstructive pulmonary disease	4.25e-05	0.000969	CbGpPWpGaD
Sertraline—Fatigue—Prednisone—chronic obstructive pulmonary disease	4.25e-05	0.000279	CcSEcCtD
Sertraline—Headache—Prednisolone—chronic obstructive pulmonary disease	4.25e-05	0.000279	CcSEcCtD
Sertraline—CYP2C9—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	4.24e-05	0.000969	CbGpPWpGaD
Sertraline—Constipation—Prednisone—chronic obstructive pulmonary disease	4.21e-05	0.000277	CcSEcCtD
Sertraline—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	4.06e-05	0.000267	CcSEcCtD
Sertraline—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	4.03e-05	0.000265	CcSEcCtD
Sertraline—Nausea—Prednisolone—chronic obstructive pulmonary disease	4.03e-05	0.000264	CcSEcCtD
Sertraline—CYP2C19—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	3.99e-05	0.000911	CbGpPWpGaD
Sertraline—CYP2C19—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	3.94e-05	0.000898	CbGpPWpGaD
Sertraline—Urticaria—Prednisone—chronic obstructive pulmonary disease	3.91e-05	0.000257	CcSEcCtD
Sertraline—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	3.89e-05	0.000256	CcSEcCtD
Sertraline—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	3.89e-05	0.000256	CcSEcCtD
Sertraline—CYP2C19—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	3.88e-05	0.000886	CbGpPWpGaD
Sertraline—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	3.88e-05	0.000886	CbGpPWpGaD
Sertraline—MAOA—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.86e-05	0.000881	CbGpPWpGaD
Sertraline—SLC6A4—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	3.84e-05	0.000876	CbGpPWpGaD
Sertraline—MAOA—Metabolism—GC—chronic obstructive pulmonary disease	3.76e-05	0.000857	CbGpPWpGaD
Sertraline—SLC6A2—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	3.73e-05	0.00085	CbGpPWpGaD
Sertraline—SLC6A2—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	3.71e-05	0.000847	CbGpPWpGaD
Sertraline—MAOA—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	3.67e-05	0.000837	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—APIP—chronic obstructive pulmonary disease	3.65e-05	0.000833	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	3.64e-05	0.000831	CbGpPWpGaD
Sertraline—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	3.63e-05	0.000238	CcSEcCtD
Sertraline—CYP2D6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	3.62e-05	0.000826	CbGpPWpGaD
Sertraline—CYP2C19—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.62e-05	0.000825	CbGpPWpGaD
Sertraline—ABCB1—Allograft Rejection—CXCL8—chronic obstructive pulmonary disease	3.6e-05	0.000821	CbGpPWpGaD
Sertraline—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—chronic obstructive pulmonary disease	3.6e-05	0.00082	CbGpPWpGaD
Sertraline—CYP2C9—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	3.59e-05	0.000819	CbGpPWpGaD
Sertraline—CYP2D6—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	3.57e-05	0.000815	CbGpPWpGaD
Sertraline—CYP2C19—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.57e-05	0.000814	CbGpPWpGaD
Sertraline—CYP2C9—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	3.54e-05	0.000808	CbGpPWpGaD
Sertraline—Asthenia—Prednisone—chronic obstructive pulmonary disease	3.53e-05	0.000232	CcSEcCtD
Sertraline—MAOA—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.49e-05	0.000797	CbGpPWpGaD
Sertraline—Pruritus—Prednisone—chronic obstructive pulmonary disease	3.48e-05	0.000229	CcSEcCtD
Sertraline—ABCB1—Allograft Rejection—IL1B—chronic obstructive pulmonary disease	3.45e-05	0.000787	CbGpPWpGaD
Sertraline—CYP2C19—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.43e-05	0.000783	CbGpPWpGaD
Sertraline—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	3.42e-05	0.000779	CbGpPWpGaD
Sertraline—CYP2C19—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.38e-05	0.000772	CbGpPWpGaD
Sertraline—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	3.38e-05	0.00077	CbGpPWpGaD
Sertraline—ABCB1—HIF-1-alpha transcription factor network—VEGFA—chronic obstructive pulmonary disease	3.37e-05	0.00077	CbGpPWpGaD
Sertraline—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	3.37e-05	0.000221	CcSEcCtD
Sertraline—CYP2D6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.33e-05	0.000759	CbGpPWpGaD
Sertraline—SLC6A3—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	3.3e-05	0.000753	CbGpPWpGaD
Sertraline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—chronic obstructive pulmonary disease	3.3e-05	0.000753	CbGpPWpGaD
Sertraline—CYP2C9—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.3e-05	0.000753	CbGpPWpGaD
Sertraline—SLC6A3—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	3.29e-05	0.00075	CbGpPWpGaD
Sertraline—CYP2D6—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.28e-05	0.000749	CbGpPWpGaD
Sertraline—MAOB—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.27e-05	0.000746	CbGpPWpGaD
Sertraline—Dizziness—Prednisone—chronic obstructive pulmonary disease	3.26e-05	0.000214	CcSEcCtD
Sertraline—CYP2C9—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.25e-05	0.000742	CbGpPWpGaD
Sertraline—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	3.24e-05	0.000738	CbGpPWpGaD
Sertraline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—chronic obstructive pulmonary disease	3.24e-05	0.000738	CbGpPWpGaD
Sertraline—MAOB—Metabolism—GCLC—chronic obstructive pulmonary disease	3.23e-05	0.000738	CbGpPWpGaD
Sertraline—CYP2D6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.15e-05	0.00072	CbGpPWpGaD
Sertraline—MAOA—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	3.14e-05	0.000718	CbGpPWpGaD
Sertraline—SLC6A2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	3.14e-05	0.000717	CbGpPWpGaD
Sertraline—Vomiting—Prednisone—chronic obstructive pulmonary disease	3.13e-05	0.000206	CcSEcCtD
Sertraline—CYP2C9—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.13e-05	0.000714	CbGpPWpGaD
Sertraline—CYP2D6—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.11e-05	0.00071	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	3.11e-05	0.00071	CbGpPWpGaD
Sertraline—Rash—Prednisone—chronic obstructive pulmonary disease	3.1e-05	0.000204	CcSEcCtD
Sertraline—Dermatitis—Prednisone—chronic obstructive pulmonary disease	3.1e-05	0.000204	CcSEcCtD
Sertraline—SLC6A4—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	3.1e-05	0.000707	CbGpPWpGaD
Sertraline—Headache—Prednisone—chronic obstructive pulmonary disease	3.08e-05	0.000203	CcSEcCtD
Sertraline—CYP2C9—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.08e-05	0.000704	CbGpPWpGaD
Sertraline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—chronic obstructive pulmonary disease	3.08e-05	0.000703	CbGpPWpGaD
Sertraline—CYP1A2—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	3.08e-05	0.000703	CbGpPWpGaD
Sertraline—CYP1A2—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	3.07e-05	0.0007	CbGpPWpGaD
Sertraline—CYP1A2—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	3.03e-05	0.00069	CbGpPWpGaD
Sertraline—MAOB—Metabolism—CTGF—chronic obstructive pulmonary disease	2.95e-05	0.000673	CbGpPWpGaD
Sertraline—Nausea—Prednisone—chronic obstructive pulmonary disease	2.92e-05	0.000192	CcSEcCtD
Sertraline—ABCB1—Allograft Rejection—VEGFA—chronic obstructive pulmonary disease	2.92e-05	0.000667	CbGpPWpGaD
Sertraline—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	2.84e-05	0.000648	CbGpPWpGaD
Sertraline—CYP1A2—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	2.82e-05	0.000643	CbGpPWpGaD
Sertraline—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	2.8e-05	0.000639	CbGpPWpGaD
Sertraline—SLC6A3—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	2.78e-05	0.000635	CbGpPWpGaD
Sertraline—CYP1A2—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	2.78e-05	0.000634	CbGpPWpGaD
Sertraline—SLC6A4—Circadian rythm related genes—TP53—chronic obstructive pulmonary disease	2.76e-05	0.00063	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—APIP—chronic obstructive pulmonary disease	2.76e-05	0.00063	CbGpPWpGaD
Sertraline—MAOB—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.72e-05	0.00062	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—APIP—chronic obstructive pulmonary disease	2.69e-05	0.000614	CbGpPWpGaD
Sertraline—ABCB1—Allograft Rejection—TGFB1—chronic obstructive pulmonary disease	2.68e-05	0.000612	CbGpPWpGaD
Sertraline—CYP1A2—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	2.67e-05	0.00061	CbGpPWpGaD
Sertraline—CYP1A2—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	2.64e-05	0.000601	CbGpPWpGaD
Sertraline—MAOA—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	2.54e-05	0.000579	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—APIP—chronic obstructive pulmonary disease	2.54e-05	0.000579	CbGpPWpGaD
Sertraline—SLC6A4—Circadian rythm related genes—IL6—chronic obstructive pulmonary disease	2.53e-05	0.000577	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—APIP—chronic obstructive pulmonary disease	2.52e-05	0.000574	CbGpPWpGaD
Sertraline—ABCB1—Allograft Rejection—TNF—chronic obstructive pulmonary disease	2.5e-05	0.000571	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.42e-05	0.000552	CbGpPWpGaD
Sertraline—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	2.37e-05	0.00054	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—GC—chronic obstructive pulmonary disease	2.35e-05	0.000537	CbGpPWpGaD
Sertraline—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	2.33e-05	0.000533	CbGpPWpGaD
Sertraline—MAOB—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.27e-05	0.000517	CbGpPWpGaD
Sertraline—MAOB—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.24e-05	0.00051	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.19e-05	0.000499	CbGpPWpGaD
Sertraline—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	2.18e-05	0.000496	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—APIP—chronic obstructive pulmonary disease	2.15e-05	0.000491	CbGpPWpGaD
Sertraline—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	2.15e-05	0.00049	CbGpPWpGaD
Sertraline—MAOB—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.08e-05	0.000475	CbGpPWpGaD
Sertraline—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	2.06e-05	0.000471	CbGpPWpGaD
Sertraline—MAOA—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.05e-05	0.000468	CbGpPWpGaD
Sertraline—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	2.03e-05	0.000464	CbGpPWpGaD
Sertraline—MAOA—Metabolism—GCLC—chronic obstructive pulmonary disease	2.03e-05	0.000463	CbGpPWpGaD
Sertraline—MAOB—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.97e-05	0.000451	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.97e-05	0.000449	CbGpPWpGaD
Sertraline—SLC6A2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.89e-05	0.00043	CbGpPWpGaD
Sertraline—MAOA—Metabolism—CTGF—chronic obstructive pulmonary disease	1.85e-05	0.000422	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.83e-05	0.000417	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	1.81e-05	0.000414	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.79e-05	0.000409	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.78e-05	0.000407	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—GC—chronic obstructive pulmonary disease	1.78e-05	0.000406	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—GC—chronic obstructive pulmonary disease	1.74e-05	0.000396	CbGpPWpGaD
Sertraline—MAOA—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.71e-05	0.000389	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.68e-05	0.000384	CbGpPWpGaD
Sertraline—SLC6A3—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.67e-05	0.000381	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.67e-05	0.00038	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	1.66e-05	0.000379	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.65e-05	0.000377	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	1.65e-05	0.000377	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—GC—chronic obstructive pulmonary disease	1.64e-05	0.000373	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—GC—chronic obstructive pulmonary disease	1.62e-05	0.00037	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.61e-05	0.000368	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.53e-05	0.00035	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.52e-05	0.000347	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.51e-05	0.000344	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	1.44e-05	0.000329	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.42e-05	0.000325	CbGpPWpGaD
Sertraline—MAOA—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.42e-05	0.000325	CbGpPWpGaD
Sertraline—MAOA—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.4e-05	0.00032	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—GC—chronic obstructive pulmonary disease	1.39e-05	0.000316	CbGpPWpGaD
Sertraline—ABCB1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	1.38e-05	0.000316	CbGpPWpGaD
Sertraline—MAOB—Metabolism—ALB—chronic obstructive pulmonary disease	1.34e-05	0.000306	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	1.32e-05	0.000302	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.32e-05	0.0003	CbGpPWpGaD
Sertraline—MAOA—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.31e-05	0.000298	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	1.3e-05	0.000296	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.29e-05	0.000294	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.29e-05	0.000293	CbGpPWpGaD
Sertraline—MAOB—Metabolism—NOS3—chronic obstructive pulmonary disease	1.28e-05	0.000293	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—GCLC—chronic obstructive pulmonary disease	1.27e-05	0.00029	CbGpPWpGaD
Sertraline—MAOA—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.24e-05	0.000283	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	1.24e-05	0.000282	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.2e-05	0.000274	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—CTGF—chronic obstructive pulmonary disease	1.16e-05	0.000265	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.1e-05	0.000251	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	1.09e-05	0.000249	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	1.07e-05	0.000244	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.07e-05	0.000244	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.03e-05	0.000234	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	9.94e-06	0.000227	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—GSTT1—chronic obstructive pulmonary disease	9.71e-06	0.000222	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—GCLC—chronic obstructive pulmonary disease	9.6e-06	0.000219	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—GSTT1—chronic obstructive pulmonary disease	9.48e-06	0.000216	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—GCLC—chronic obstructive pulmonary disease	9.37e-06	0.000214	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	8.95e-06	0.000204	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—GSTT1—chronic obstructive pulmonary disease	8.93e-06	0.000204	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—GSTP1—chronic obstructive pulmonary disease	8.91e-06	0.000203	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—GSTT1—chronic obstructive pulmonary disease	8.86e-06	0.000202	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—GCLC—chronic obstructive pulmonary disease	8.83e-06	0.000201	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—HMOX1—chronic obstructive pulmonary disease	8.79e-06	0.0002	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—CTGF—chronic obstructive pulmonary disease	8.76e-06	0.0002	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—GCLC—chronic obstructive pulmonary disease	8.75e-06	0.0002	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—CTGF—chronic obstructive pulmonary disease	8.55e-06	0.000195	CbGpPWpGaD
Sertraline—MAOA—Metabolism—ALB—chronic obstructive pulmonary disease	8.42e-06	0.000192	CbGpPWpGaD
Sertraline—ABCB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	8.31e-06	0.00019	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.19e-06	0.000187	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	8.16e-06	0.000186	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.07e-06	0.000184	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	8.06e-06	0.000184	CbGpPWpGaD
Sertraline—MAOA—Metabolism—NOS3—chronic obstructive pulmonary disease	8.06e-06	0.000184	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—CTGF—chronic obstructive pulmonary disease	7.99e-06	0.000182	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	7.88e-06	0.00018	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.76e-06	0.000177	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	7.57e-06	0.000173	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	7.48e-06	0.000171	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	7.42e-06	0.000169	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	7.36e-06	0.000168	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	6.97e-06	0.000159	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	6.83e-06	0.000156	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.73e-06	0.000154	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.64e-06	0.000152	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.57e-06	0.00015	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.48e-06	0.000148	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.19e-06	0.000141	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.19e-06	0.000141	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.14e-06	0.00014	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.11e-06	0.000139	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.05e-06	0.000138	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.04e-06	0.000138	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.86e-06	0.000134	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	5.84e-06	0.000133	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	5.77e-06	0.000132	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.72e-06	0.000131	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.69e-06	0.00013	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.64e-06	0.000129	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.39e-06	0.000123	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.35e-06	0.000122	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—ALB—chronic obstructive pulmonary disease	5.28e-06	0.00012	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	5.27e-06	0.00012	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.25e-06	0.00012	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.17e-06	0.000118	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—NOS3—chronic obstructive pulmonary disease	5.05e-06	0.000115	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.85e-06	0.000111	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.82e-06	0.00011	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.57e-06	0.000104	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.05e-06	9.24e-05	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.99e-06	9.11e-05	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—ALB—chronic obstructive pulmonary disease	3.99e-06	9.1e-05	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—ALB—chronic obstructive pulmonary disease	3.89e-06	8.88e-05	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—NOS3—chronic obstructive pulmonary disease	3.81e-06	8.7e-05	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—NOS3—chronic obstructive pulmonary disease	3.72e-06	8.49e-05	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.72e-06	8.49e-05	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	3.67e-06	8.37e-05	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—ALB—chronic obstructive pulmonary disease	3.63e-06	8.29e-05	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.53e-06	8.05e-05	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	3.51e-06	8e-05	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—NOS3—chronic obstructive pulmonary disease	3.48e-06	7.93e-05	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—ALB—chronic obstructive pulmonary disease	3.11e-06	7.09e-05	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	2.97e-06	6.78e-05	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	2.4e-06	5.47e-05	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	2.29e-06	5.23e-05	CbGpPWpGaD
